top
Search terms
Results 1 - 4 of 4 - ordered by :
Ehjournal

Allocation to rosuvastatin when compared with placebo was associated with a 27% reduction in the relative risk of developing AF during the trial period; specifically, AF was reported among 138 ...

European Heart Journal, Peña, Jessica M., MacFadyen, Jean, Glynn, Robert J., Ridker, Paul M

Date : 01/02/2012 Item size : 251353 bytes
Ehjournal

Allocation to rosuvastatin when compared with placebo was associated with a 27% reduction in the relative risk of developing AF during the trial period; specifically, AF was reported among 138 ...

European Heart Journal, Peña, Jessica M., MacFadyen, Jean, Glynn, Robert J., Ridker, Paul M

Date : 01/02/2012 Item size : 244442 bytes
Ehjournal

Prevention has experienced enormous progress over the last decades with the development of effective antihypertensive drugs and then aspirin and statins1 as outlined in the most recent ESC ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/08/2017 Item size : 218722 bytes
Escardio

Better treatment options for preventing cardiovascular disease are needed, particularly in very high risk patients such as those with diabetic complications. “The correlation between lower ...

Date : 29/08/2017